Clinical Trial Results: Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation

View source ↗

Summary

A completed clinical trial evaluating glistening, visual outcomes, and general safety 24 months after intraocular lens implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Snippet

Sponsor: Carl Zeiss Meditec AG | Conditions: Cataract Senile | Status: COMPLETED | Results posted: 2026-08-19